These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Headache in idiopathic intracranial hypertension. A CGRP-dependent head pain? De Simone R; Sansone M; Bonavita V Neurol Sci; 2020 Dec; 41(Suppl 2):417-421. PubMed ID: 32852682 [TBL] [Abstract][Full Text] [Related]
8. High-pressure headaches: idiopathic intracranial hypertension and its mimics. Peng KP; Fuh JL; Wang SJ Nat Rev Neurol; 2012 Dec; 8(12):700-10. PubMed ID: 23165338 [TBL] [Abstract][Full Text] [Related]
9. Advances in the understanding of headache in idiopathic intracranial hypertension. Mollan SP; Hoffmann J; Sinclair AJ Curr Opin Neurol; 2019 Feb; 32(1):92-98. PubMed ID: 30547900 [TBL] [Abstract][Full Text] [Related]
10. Randomised controlled trial of bariatric surgery versus a community weight loss programme for the sustained treatment of idiopathic intracranial hypertension: the Idiopathic Intracranial Hypertension Weight Trial (IIH:WT) protocol. Ottridge R; Mollan SP; Botfield H; Frew E; Ives NJ; Matthews T; Mitchell J; Rick C; Singhal R; Woolley R; Sinclair AJ BMJ Open; 2017 Sep; 7(9):e017426. PubMed ID: 28963303 [TBL] [Abstract][Full Text] [Related]
11. History and Review of anti-Calcitonin Gene-Related Peptide (CGRP) Therapies: From Translational Research to Treatment. Tepper SJ Headache; 2018 Nov; 58 Suppl 3():238-275. PubMed ID: 30242830 [TBL] [Abstract][Full Text] [Related]
13. Cluster-like headache and idiopathic intracranial hypertension: a case report. Testa L; Mittino D; Terazzi E; Mula M; Monaco F J Headache Pain; 2008 Jun; 9(3):181-3. PubMed ID: 18418548 [TBL] [Abstract][Full Text] [Related]
14. Incidence and predictors of dural venous sinus pressure gradient in idiopathic intracranial hypertension and non-idiopathic intracranial hypertension headache patients: results from 164 cerebral venograms. Levitt MR; Hlubek RJ; Moon K; Kalani MY; Nakaji P; Smith KA; Little AS; Knievel K; Chan JW; McDougall CG; Albuquerque FC J Neurosurg; 2017 Feb; 126(2):347-353. PubMed ID: 26967777 [TBL] [Abstract][Full Text] [Related]
15. Headache, Opiate Use, and Prescribing Trends in Women With Idiopathic Intracranial Hypertension: A Population-Based Matched Cohort Study. Adderley NJ; Subramanian A; Perrins M; Nirantharakumar K; Mollan SP; Sinclair AJ Neurology; 2022 Oct; 99(18):e1968-e1978. PubMed ID: 35985824 [TBL] [Abstract][Full Text] [Related]
16. Anti-Calcitonin Gene-Related Peptide (CGRP) Therapies: Update on a Previous Review After the American Headache Society 60th Scientific Meeting, San Francisco, June 2018. Tepper SJ Headache; 2018 Nov; 58 Suppl 3():276-290. PubMed ID: 30403405 [TBL] [Abstract][Full Text] [Related]
17. Headache prevalence and clinical features in patients with idiopathic intracranial hypertension (IIH). D Amico D; Curone M; Ciasca P; Cammarata G; Melzi L; Bussone G; Bianchi Marzoli S Neurol Sci; 2013 May; 34 Suppl 1():S147-9. PubMed ID: 23695067 [TBL] [Abstract][Full Text] [Related]
18. Headache diagnoses in patients with treated idiopathic intracranial hypertension. Friedman DI; Rausch EA Neurology; 2002 May; 58(10):1551-3. PubMed ID: 12034799 [TBL] [Abstract][Full Text] [Related]
19. Migraine induction with calcitonin gene-related peptide in patients from erenumab trials. Christensen CE; Younis S; Deen M; Khan S; Ghanizada H; Ashina M J Headache Pain; 2018 Nov; 19(1):105. PubMed ID: 30409109 [TBL] [Abstract][Full Text] [Related]
20. Case series of six patients diagnosed and managed for idiopathic intracranial hypertension at a tertiary institution eye centre. Tagoe NN; Beyuo VM; Amissah-Arthur KN Ghana Med J; 2019 Mar; 53(1):79-87. PubMed ID: 31138948 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]